The severity of human infection by one of the many Shiga toxin-producing Escherichia coli
(STEC) is determined by a number of factors: the bacterial genome, the capacity of human …

Enteropathogenic Escherichia coli are commonly classified pathotypically, by the patterns of
manifestations observed in infection (Table 1). However, these descriptively useful terms …

Escherichia coli comprises a highly diverse group of Gram‐negative bacteria and is a
common member of the intestinal microflora of humans and animals. Generally, such …

Emerging public health challenges of Shiga toxin (stx)–producing Escherichia coli (STEC)
include the occurrence of more frequent or severe disease and risk factors shifts associated …

Background Shiga-toxin E. coli infections remain a public health concern because of the
severity of the gastrointestinal illness and associated complications. Transmission pathways …

Signs and symptoms of Shiga toxin–producing Escherichia coli (STEC) serogroup O157: H7
infection range from mild gastrointestinal to bloody diarrhea and hemolytic uremic syndrome …

Background Shiga toxin-producing E. coli (STEC) infection is associated with haemolytic
uremic syndrome (HUS). Therefore Norway has implemented strict guidelines for prevention …

The appearance of highly pathogenic strains of Shiga toxin (Stx)-producingEscherichia. coli
(STEC) has owed largely to the acquisition of Stx-encoding prophages by strains of E. coli …

Shiga toxin-producing Escherichia coli (STEC) is an important foodborne pathogen. The
increasing incidence of non-O157 STEC has posed a great risk to public health. Besides the …

Objectives Shiga toxin-producing Escherichia coli (STEC) are zoonotic and transmission to
humans occurs via contaminated food or contact with infected animals. In this study, WGS …